References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
deCupisetal(1995)Comparisonbetweennovelsteroid-likeandconventionalnonsteroidalantioestrogensininhibitingoestrADIolandIGF-Iinducedproliferationofhumanbreastcancer-derivedcells.Br.J.Pharmacol.1162391PMID:8581274
Howelletal(2000)ICI182,780(FaslodexTM):Developmentofanovel,"pure"antiestrogen.Cancer89817PMID:10951345
Thomasetal(2005)IdentityofanestrogenmembranereceptorcoupledtoaGproteininhumanbreastcancercells.Endocrinology.146624PMID:15539556
Wakelingetal(1991)Apotentspecificpureantiestrogenwithclinicalpotential.CancerRes.513867PMID:1855205
Keywords:ICI182,780,supplier,High,affinity,GPR30,agonist,Estrogen,receptors,antagonists,ER,ERR,ICI182780,AstraZeneca,GPER,Estrogen,and,Related,Receptors,Estrogen,(GPER),Receptors,Estrogen,and,Related,Receptors,TocrisBioscience